164 related articles for article (PubMed ID: 7489367)
21. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
22. New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.
Eghtedari M; Sarrafi Y; Nadri H; Mahdavi M; Moradi A; Homayouni Moghadam F; Emami S; Firoozpour L; Asadipour A; Sabzevari O; Foroumadi A
Eur J Med Chem; 2017 Mar; 128():237-246. PubMed ID: 28189905
[TBL] [Abstract][Full Text] [Related]
23. Molecular dissection of cholinesterase domains responsible for carbamate toxicity.
Loewenstein Y; Denarie M; Zakut H; Soreq H
Chem Biol Interact; 1993 Jun; 87(1-3):209-16. PubMed ID: 8343977
[TBL] [Abstract][Full Text] [Related]
24. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
25. Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity.
Markowicz-Piasecka M; Sikora J; Mateusiak Ł; Mikiciuk-Olasik E; Huttunen KM
Oxid Med Cell Longev; 2017; 2017():7303096. PubMed ID: 28770024
[TBL] [Abstract][Full Text] [Related]
26. Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile.
Strelnik AD; Petukhov AS; Zueva IV; Zobov VV; Petrov KA; Nikolsky EE; Balakin KV; Bachurin SO; Shtyrlin YG
Bioorg Med Chem Lett; 2016 Aug; 26(16):4092-4. PubMed ID: 27377327
[TBL] [Abstract][Full Text] [Related]
27. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors.
da Costa JS; Lopes JP; Russowsky D; Petzhold CL; Borges AC; Ceschi MA; Konrath E; Batassini C; Lunardi PS; Gonçalves CA
Eur J Med Chem; 2013 Apr; 62():556-63. PubMed ID: 23422935
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives.
Lopes JPB; Silva L; da Costa Franarin G; Antonio Ceschi M; Seibert Lüdtke D; Ferreira Dantas R; de Salles CMC; Paes Silva-Jr F; Roberto Senger M; Alvim Guedes I; Emmanuel Dardenne L
Bioorg Med Chem; 2018 Nov; 26(20):5566-5577. PubMed ID: 30340901
[TBL] [Abstract][Full Text] [Related]
30. Butyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans.
Steele L; Lockridge O; Gerkovich MM; Cook MR; Sastre A
Environ Health; 2015 Jan; 14():4. PubMed ID: 25575675
[TBL] [Abstract][Full Text] [Related]
31. Normal and atypical butyrylcholinesterases in placental development, function, and malfunction.
Sternfeld M; Rachmilewitz J; Loewenstein-Lichtenstein Y; Andres C; Timberg R; Ben-Ari S; Glick C; Soreq H; Zakut H
Cell Mol Neurobiol; 1997 Jun; 17(3):315-32. PubMed ID: 9187488
[TBL] [Abstract][Full Text] [Related]
32. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
34. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Thomsen T; Zendeh B; Fischer JP; Kewitz H
Biochem Pharmacol; 1991 Jan; 41(1):139-41. PubMed ID: 1986738
[No Abstract] [Full Text] [Related]
36. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.
Neville LF; Gnatt A; Loewenstein Y; Seidman S; Ehrlich G; Soreq H
EMBO J; 1992 Apr; 11(4):1641-9. PubMed ID: 1373381
[TBL] [Abstract][Full Text] [Related]
37. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
38. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
39. Effects of inescapable stress and treatment with pyridostigmine bromide on plasma butyrylcholinesterase and the acoustic startle response in rats.
Servatius RJ; Ottenweller JE; Guo W; Beldowicz D; Zhu G; Natelson BH
Physiol Behav; 2000 May; 69(3):239-46. PubMed ID: 10869589
[TBL] [Abstract][Full Text] [Related]
40. Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
Darvesh S; Arora RC; Martin E; Magee D; Hopkins DA; Armour JA
Exp Neurol; 2004 Aug; 188(2):461-70. PubMed ID: 15246845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]